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Mood stabilizers represent a class of drugs that are used in
the treatment of bipolar disorder, as prophylactic agents
against future episodes and as adjunctive antidepressant
medication. The anticonvulsant drugs such as valproic
acid and carbamazepine are efficacious drugs in the treat-
ment of epilepsy and bipolar disorder. Regarding the way
that these drugs exhibit their therapeutic effect in the
above disorders, many mechanisms have been postulated.
Among them regulation of the glutamate excitatory neu-
rotransmission and GABA inhibitory neurotransmission
are mostly studied mechanisms of anticonvulsants. Quite
important extracellular effects of these drugs have not
been excluded, as most available evidence suggests that
the therapeutically relevant class of medications are in the
interior of the cells. The mood stabilizers have been
shown to modulate the activity of enzymes, ions, arachi-
donic acid turn over, G-protein coupled receptors and
intracellular pathways involved in synaptic plasticity and
neuroprotection. Understanding the therapeutic targets of
mood stabilizers will undoubtedly lead to a better under-
standing of the pathophysiology of bipolar disorder and
to the development of improved therapeutics for the treat-
ment of this disease.
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